I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
MET exon 14 skipping mutation is a hepatocyte growth factor..:
Hoggard, B
;
Jamme, Philippe
;
Paget, Sonia
...
10.1002/1878-0261.13397. , 2024
Link:
https://hdl.handle.net/20.500.12210/95725
RT Journal T1
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanized HGF knock-in mice
UL https://suche.suub.uni-bremen.de/peid=base-ftunivlilleoa:oai:lilloa.univ-lille.fr:20.500.12210_95725&Exemplar=1&LAN=DE A1 Hoggard, B A1 Jamme, Philippe A1 Paget, Sonia A1 Truong, Marie-Jose A1 Grégoire, V A1 Vinchent, Audrey A1 Descarpentries, C A1 Morabito, Angela A1 Stanislovas, J A1 Farage, E A1 Meneboo, Jean-Pascal A1 Sebda, Shéhérazade A1 Bouchekioua-Bouzaghou, K A1 Nollet, M A1 Humez, Sarah A1 Perera, T A1 Fromme, P A1 Grumolato, L A1 Figeac, Martin A1 Copin, Marie-Christine A1 Tulasne, David A1 Cortot, Alexis A1 Kermorgant, S A1 Kherrouche, Zoulika YR 2024 K1 hepatocyte growth factor;lung cancer;preclinical models;targeted therapies;transcriptomic;tyrosine kinase receptor JF 10.1002/1878-0261.13397 LK http://dx.doi.org/https://hdl.handle.net/20.500.12210/95725 DO https://hdl.handle.net/20.500.12210/95725 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)